HEADER TRANSFERASE 22-MAR-99 4PGT TITLE CRYSTAL STRUCTURE OF HGSTP1-1[V104] COMPLEXED WITH THE GSH CONJUGATE TITLE 2 OF (+)-ANTI-BPDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEIN (GLUTATHIONE S-TRANSFERASE); COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: GST, HGSTP1-1[V104]; COMPND 5 EC: 2.5.1.18; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES; COMPND 8 OTHER_DETAILS: HGSTP1-1[V104] AND HGSTP1-1[I104] ARE NATURALLY COMPND 9 OCCURRING VARIANTS OF HGSTP1-1 OBTAINED BY SITE-DIRECTED MUTAGENESIS SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 STRAIN: BL21 (DE3) PLYSS; SOURCE 6 ORGAN: PLACENTA; SOURCE 7 CELLULAR_LOCATION: CYTOPLASM; SOURCE 8 GENE: GTP_HUMAN; SOURCE 9 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 10 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 11 EXPRESSION_SYSTEM_STRAIN: BL21 (DE3) PLYSS KEYWDS TRANSFERASE, PI CLASS, HGSTP1-1[V104], DETOXIFICATION EXPDTA X-RAY DIFFRACTION AUTHOR X.JI,J.BLASZCZYK REVDAT 9 13-NOV-24 4PGT 1 REMARK REVDAT 8 15-NOV-23 4PGT 1 REMARK REVDAT 7 30-AUG-23 4PGT 1 AUTHOR JRNL REMARK LINK REVDAT 6 13-NOV-19 4PGT 1 JRNL SEQADV LINK REVDAT 5 07-MAR-18 4PGT 1 REMARK REVDAT 4 24-FEB-09 4PGT 1 VERSN REVDAT 3 01-APR-03 4PGT 1 JRNL REVDAT 2 10-JAN-01 4PGT 1 CRYST1 REMARK REVDAT 1 01-SEP-99 4PGT 0 JRNL AUTH X.JI,J.BLASZCZYK,B.XIAO,R.O'DONNELL,X.HU,C.HERZOG,S.V.SINGH, JRNL AUTH 2 P.ZIMNIAK JRNL TITL STRUCTURE AND FUNCTION OF RESIDUE 104 AND WATER MOLECULES IN JRNL TITL 2 THE XENOBIOTIC SUBSTRATE-BINDING SITE IN HUMAN GLUTATHIONE JRNL TITL 3 S-TRANSFERASE P1-1. JRNL REF BIOCHEMISTRY V. 38 10231 1999 JRNL REFN ISSN 0006-2960 JRNL PMID 10441116 JRNL DOI 10.1021/BI990668U REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH X.JI,M.TORDOVA,R.O'DONNELL,J.F.PARSONS,J.B.HAYDEN, REMARK 1 AUTH 2 G.L.GILLILAND,P.ZIMNIAK REMARK 1 TITL STRUCTURE AND FUNCTION OF THE XENOBIOTIC SUBSTRATE-BINDING REMARK 1 TITL 2 SITE AND LOCATION OF A POTENTIAL NON-SUBSTRATE-BINDING SITE REMARK 1 TITL 3 IN A CLASS PI GLUTATHIONE S-TRANSFERASE. REMARK 1 REF BIOCHEMISTRY V. 36 9690 1997 REMARK 1 REFN ISSN 0006-2960 REMARK 1 PMID 9245401 REMARK 1 DOI 10.1021/BI970805S REMARK 1 REFERENCE 2 REMARK 1 AUTH P.ZIMNIAK,B.NANDURI,S.PIKULA,J.BANDOROWICZ-PIKULA, REMARK 1 AUTH 2 S.S.SINGHAL,S.K.SRIVASTAVA,S.AWASTHI,Y.C.AWASTHI REMARK 1 TITL NATURALLY OCCURRING HUMAN GLUTATHIONE S-TRANSFERASE GSTP1-1 REMARK 1 TITL 2 ISOFORMS WITH ISOLEUCINE AND VALINE IN POSITION 104 DIFFER REMARK 1 TITL 3 IN ENZYMIC PROPERTIES. REMARK 1 REF EUR.J.BIOCHEM. V. 224 893 1994 REMARK 1 REFN ISSN 0014-2956 REMARK 1 PMID 7925413 REMARK 1 DOI 10.1111/J.1432-1033.1994.00893.X REMARK 1 REFERENCE 3 REMARK 1 AUTH P.REINEMER,H.W.DIRR,R.LADENSTEIN,R.HUBER,M.LO BELLO, REMARK 1 AUTH 2 G.FEDERICI,M.W.PARKER REMARK 1 TITL THREE-DIMENSIONAL STRUCTURE OF CLASS PI GLUTATHIONE REMARK 1 TITL 2 S-TRANSFERASE FROM HUMAN PLACENTA IN COMPLEX WITH REMARK 1 TITL 3 S-HEXYLGLUTATHIONE AT 2.8 A RESOLUTION. REMARK 1 REF J.MOL.BIOL. V. 227 214 1992 REMARK 1 REFN ISSN 0022-2836 REMARK 1 PMID 1522586 REMARK 1 DOI 10.1016/0022-2836(92)90692-D REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : SHELXL REMARK 3 AUTHORS : G.M.SHELDRICK REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 93.8 REMARK 3 CROSS-VALIDATION METHOD : FREE R (AT EARLY STAGE) REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (NO CUTOFF). REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.190 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.190 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.179 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 25782 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F). REMARK 3 R VALUE (WORKING + TEST SET, F>4SIG(F)) : 0.180 REMARK 3 R VALUE (WORKING SET, F>4SIG(F)) : 0.180 REMARK 3 FREE R VALUE (F>4SIG(F)) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (F>4SIG(F)) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (F>4SIG(F)) : 21523 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3284 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 120 REMARK 3 SOLVENT ATOMS : 427 REMARK 3 REMARK 3 MODEL REFINEMENT. REMARK 3 OCCUPANCY SUM OF NON-HYDROGEN ATOMS : 3830.5 REMARK 3 OCCUPANCY SUM OF HYDROGEN ATOMS : 0.00 REMARK 3 NUMBER OF DISCRETELY DISORDERED RESIDUES : 0 REMARK 3 NUMBER OF LEAST-SQUARES PARAMETERS : 15337 REMARK 3 NUMBER OF RESTRAINTS : 14004 REMARK 3 REMARK 3 RMS DEVIATIONS FROM RESTRAINT TARGET VALUES. REMARK 3 BOND LENGTHS (A) : 0.004 REMARK 3 ANGLE DISTANCES (A) : 0.017 REMARK 3 SIMILAR DISTANCES (NO TARGET VALUES) (A) : 0.000 REMARK 3 DISTANCES FROM RESTRAINT PLANES (A) : 0.019 REMARK 3 ZERO CHIRAL VOLUMES (A**3) : 0.023 REMARK 3 NON-ZERO CHIRAL VOLUMES (A**3) : 0.026 REMARK 3 ANTI-BUMPING DISTANCE RESTRAINTS (A) : 0.016 REMARK 3 RIGID-BOND ADP COMPONENTS (A**2) : 0.000 REMARK 3 SIMILAR ADP COMPONENTS (A**2) : 0.039 REMARK 3 APPROXIMATELY ISOTROPIC ADPS (A**2) : 0.000 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED: MOEWS & KRETSINGER, J.MOL.BIOL.91(1973)201-2 REMARK 3 REMARK 3 STEREOCHEMISTRY TARGET VALUES : ENGH AND HUBER REMARK 3 SPECIAL CASE: NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: X-PLOR WAS USED AT THE EARLY STAGE OF REMARK 3 THE REFINEMENT. REMARK 4 REMARK 4 4PGT COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 23-MAR-99. REMARK 100 THE DEPOSITION ID IS D_1000000697. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : MAR-97 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : ENRAF-NONIUS FR591 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NI FILTER REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MAC SCIENCE DIP-2020 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 25842 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 90.8 REMARK 200 DATA REDUNDANCY : 3.300 REMARK 200 R MERGE (I) : 0.06400 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 13.8700 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.19 REMARK 200 COMPLETENESS FOR SHELL (%) : 81.0 REMARK 200 DATA REDUNDANCY IN SHELL : 2.32 REMARK 200 R MERGE FOR SHELL (I) : 0.15900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 4.280 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: X-PLOR REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.13 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: CRYSTALS WERE GROWN IN HANGING DROPS REMARK 280 WHICH INITIALLY CONSISTED OF 4.3 MG/ML PROTEIN, 0.55 MM GSH REMARK 280 CONJUGATE OF (+)-ANTI-BPDE, 0.8 M AMMONIUM SULFATE IN 50 MM MES REMARK 280 BUFFER (PH 6.0). THE DROPS WERE EQUILIBRATED AT 293 K AGAINST REMARK 280 WELL SOLUTION CONTAINING 1.6 M AMMONIUM SULFATE IN 0.1 M MES REMARK 280 BUFFER (PH 6.0). REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 39.04500 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 44.92000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 39.04500 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 44.92000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5120 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 17950 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -33.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 727 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET B 0 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 64 106.33 78.45 REMARK 500 LEU A 78 51.40 -119.43 REMARK 500 TYR A 79 33.60 -140.83 REMARK 500 ASN A 110 37.14 -155.75 REMARK 500 THR A 141 -112.05 -115.98 REMARK 500 GLN B 64 112.33 84.46 REMARK 500 LEU B 78 55.04 -115.18 REMARK 500 TYR B 79 37.17 -143.84 REMARK 500 ASN B 110 43.43 -157.70 REMARK 500 THR B 141 -107.29 -111.42 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 210 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 210 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GBX A 211 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MES A 212 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GBX B 211 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MES B 212 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1PGT RELATED DB: PDB REMARK 900 RELATED ID: 2PGT RELATED DB: PDB REMARK 900 RELATED ID: 3PGT RELATED DB: PDB DBREF 4PGT A 0 209 UNP P09211 GSTP1_HUMAN 1 210 DBREF 4PGT B 0 209 UNP P09211 GSTP1_HUMAN 1 210 SEQADV 4PGT VAL A 104 UNP P09211 ILE 104 VARIANT SEQADV 4PGT VAL B 104 UNP P09211 ILE 104 VARIANT SEQRES 1 A 210 MET PRO PRO TYR THR VAL VAL TYR PHE PRO VAL ARG GLY SEQRES 2 A 210 ARG CYS ALA ALA LEU ARG MET LEU LEU ALA ASP GLN GLY SEQRES 3 A 210 GLN SER TRP LYS GLU GLU VAL VAL THR VAL GLU THR TRP SEQRES 4 A 210 GLN GLU GLY SER LEU LYS ALA SER CYS LEU TYR GLY GLN SEQRES 5 A 210 LEU PRO LYS PHE GLN ASP GLY ASP LEU THR LEU TYR GLN SEQRES 6 A 210 SER ASN THR ILE LEU ARG HIS LEU GLY ARG THR LEU GLY SEQRES 7 A 210 LEU TYR GLY LYS ASP GLN GLN GLU ALA ALA LEU VAL ASP SEQRES 8 A 210 MET VAL ASN ASP GLY VAL GLU ASP LEU ARG CSO LYS TYR SEQRES 9 A 210 VAL SER LEU ILE TYR THR ASN TYR GLU ALA GLY LYS ASP SEQRES 10 A 210 ASP TYR VAL LYS ALA LEU PRO GLY GLN LEU LYS PRO PHE SEQRES 11 A 210 GLU THR LEU LEU SER GLN ASN GLN GLY GLY LYS THR PHE SEQRES 12 A 210 ILE VAL GLY ASP GLN ILE SER PHE ALA ASP TYR ASN LEU SEQRES 13 A 210 LEU ASP LEU LEU LEU ILE HIS GLU VAL LEU ALA PRO GLY SEQRES 14 A 210 CYS LEU ASP ALA PHE PRO LEU LEU SER ALA TYR VAL GLY SEQRES 15 A 210 ARG LEU SER ALA ARG PRO LYS LEU LYS ALA PHE LEU ALA SEQRES 16 A 210 SER PRO GLU TYR VAL ASN LEU PRO ILE ASN GLY ASN GLY SEQRES 17 A 210 LYS GLN SEQRES 1 B 210 MET PRO PRO TYR THR VAL VAL TYR PHE PRO VAL ARG GLY SEQRES 2 B 210 ARG CYS ALA ALA LEU ARG MET LEU LEU ALA ASP GLN GLY SEQRES 3 B 210 GLN SER TRP LYS GLU GLU VAL VAL THR VAL GLU THR TRP SEQRES 4 B 210 GLN GLU GLY SER LEU LYS ALA SER CYS LEU TYR GLY GLN SEQRES 5 B 210 LEU PRO LYS PHE GLN ASP GLY ASP LEU THR LEU TYR GLN SEQRES 6 B 210 SER ASN THR ILE LEU ARG HIS LEU GLY ARG THR LEU GLY SEQRES 7 B 210 LEU TYR GLY LYS ASP GLN GLN GLU ALA ALA LEU VAL ASP SEQRES 8 B 210 MET VAL ASN ASP GLY VAL GLU ASP LEU ARG CSO LYS TYR SEQRES 9 B 210 VAL SER LEU ILE TYR THR ASN TYR GLU ALA GLY LYS ASP SEQRES 10 B 210 ASP TYR VAL LYS ALA LEU PRO GLY GLN LEU LYS PRO PHE SEQRES 11 B 210 GLU THR LEU LEU SER GLN ASN GLN GLY GLY LYS THR PHE SEQRES 12 B 210 ILE VAL GLY ASP GLN ILE SER PHE ALA ASP TYR ASN LEU SEQRES 13 B 210 LEU ASP LEU LEU LEU ILE HIS GLU VAL LEU ALA PRO GLY SEQRES 14 B 210 CYS LEU ASP ALA PHE PRO LEU LEU SER ALA TYR VAL GLY SEQRES 15 B 210 ARG LEU SER ALA ARG PRO LYS LEU LYS ALA PHE LEU ALA SEQRES 16 B 210 SER PRO GLU TYR VAL ASN LEU PRO ILE ASN GLY ASN GLY SEQRES 17 B 210 LYS GLN MODRES 4PGT CSO A 101 CYS S-HYDROXYCYSTEINE MODRES 4PGT CSO B 101 CYS S-HYDROXYCYSTEINE HET CSO A 101 7 HET CSO B 101 7 HET SO4 A 210 5 HET GBX A 211 43 HET MES A 212 12 HET SO4 B 210 5 HET GBX B 211 43 HET MES B 212 12 HETNAM CSO S-HYDROXYCYSTEINE HETNAM SO4 SULFATE ION HETNAM GBX 2-AMINO-4-[1-(CARBOXYMETHYL-CARBAMOYL)-2-(9-HYDROXY-7, HETNAM 2 GBX 8-DIOXO-7,8,9,10-TETRAHYDRO-BENZO[DEF]CHRYSEN-10- HETNAM 3 GBX YLSULFANYL)-ETHYLCARBAMOYL]-BUTYRIC ACID HETNAM MES 2-(N-MORPHOLINO)-ETHANESULFONIC ACID HETSYN GBX GLUTATHIONE CONJUGATE OF (+)-ANTI-BPDE FORMUL 1 CSO 2(C3 H7 N O3 S) FORMUL 3 SO4 2(O4 S 2-) FORMUL 4 GBX 2(C30 H27 N3 O9 S) FORMUL 5 MES 2(C6 H13 N O4 S) FORMUL 9 HOH *427(H2 O) HELIX 1 1 GLY A 12 ASP A 23 5 12 HELIX 2 2 VAL A 35 GLU A 40 1 6 HELIX 3 3 SER A 42 SER A 46 1 5 HELIX 4 4 SER A 65 THR A 75 1 11 HELIX 5 5 GLN A 83 THR A 109 1 27 HELIX 6 6 TYR A 111 GLN A 135 1 25 HELIX 7 7 GLN A 137 GLY A 139 5 3 HELIX 8 8 PHE A 150 LEU A 165 1 16 HELIX 9 9 CYS A 169 ALA A 172 5 4 HELIX 10 10 PRO A 174 ALA A 185 1 12 HELIX 11 11 PRO A 187 LEU A 193 1 7 HELIX 12 12 PRO A 196 VAL A 199 1 4 HELIX 13 13 GLY B 12 ASP B 23 5 12 HELIX 14 14 VAL B 35 GLU B 40 1 6 HELIX 15 15 SER B 42 SER B 46 1 5 HELIX 16 16 SER B 65 LEU B 76 1 12 HELIX 17 17 GLN B 83 THR B 109 1 27 HELIX 18 18 TYR B 111 GLN B 135 1 25 HELIX 19 19 GLN B 137 GLY B 139 5 3 HELIX 20 20 PHE B 150 LEU B 165 1 16 HELIX 21 21 PRO B 174 ALA B 185 1 12 HELIX 22 22 PRO B 187 ALA B 194 1 8 HELIX 23 23 PRO B 196 VAL B 199 1 4 SHEET 1 A 4 LYS A 29 VAL A 33 0 SHEET 2 A 4 TYR A 3 PHE A 8 1 N VAL A 5 O LYS A 29 SHEET 3 A 4 LYS A 54 ASP A 57 -1 N GLN A 56 O THR A 4 SHEET 4 A 4 LEU A 60 TYR A 63 -1 N LEU A 62 O PHE A 55 SHEET 1 B 4 TRP B 28 VAL B 33 0 SHEET 2 B 4 TYR B 3 PHE B 8 1 N TYR B 3 O LYS B 29 SHEET 3 B 4 LYS B 54 ASP B 57 -1 N GLN B 56 O THR B 4 SHEET 4 B 4 LEU B 60 TYR B 63 -1 N LEU B 62 O PHE B 55 LINK C ARG A 100 N CSO A 101 1555 1555 1.34 LINK C CSO A 101 N LYS A 102 1555 1555 1.33 LINK C ARG B 100 N CSO B 101 1555 1555 1.33 LINK C CSO B 101 N LYS B 102 1555 1555 1.33 CISPEP 1 LEU A 52 PRO A 53 0 1.69 CISPEP 2 LEU B 52 PRO B 53 0 6.00 SITE 1 AC1 6 PHE A 142 GLN A 147 ILE A 148 ARG A 186 SITE 2 AC1 6 HOH A 621 HOH A 677 SITE 1 AC2 1 ARG B 186 SITE 1 AC3 19 TYR A 7 PHE A 8 ARG A 13 TRP A 38 SITE 2 AC3 19 LYS A 44 GLN A 51 LEU A 52 PRO A 53 SITE 3 AC3 19 GLN A 64 SER A 65 TYR A 108 GLY A 205 SITE 4 AC3 19 HOH A 310 HOH A 317 HOH A 383 HOH A 426 SITE 5 AC3 19 HOH A 589 HOH A 703 ASP B 98 SITE 1 AC4 9 ALA A 22 TRP A 28 GLU A 30 PHE A 192 SITE 2 AC4 9 GLU A 197 HOH A 389 HOH A 490 HOH A 500 SITE 3 AC4 9 ASP B 171 SITE 1 AC5 19 ASP A 98 TYR B 7 PHE B 8 VAL B 10 SITE 2 AC5 19 ARG B 13 TRP B 38 LYS B 44 GLY B 50 SITE 3 AC5 19 GLN B 51 LEU B 52 PRO B 53 GLN B 64 SITE 4 AC5 19 SER B 65 TYR B 108 GLY B 205 HOH B 307 SITE 5 AC5 19 HOH B 326 HOH B 476 HOH B 681 SITE 1 AC6 9 ASP A 171 ALA A 172 ALA B 22 TRP B 28 SITE 2 AC6 9 GLU B 30 GLU B 197 HOH B 403 HOH B 492 SITE 3 AC6 9 HOH B 523 CRYST1 78.090 89.840 68.780 90.00 98.13 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012806 0.000000 0.001829 0.00000 SCALE2 0.000000 0.011131 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014687 0.00000 MTRIX1 1 0.933018 -0.145598 0.329057 -4.56586 1 MTRIX2 1 -0.144160 -0.989132 -0.028905 2.99651 1 MTRIX3 1 0.329689 -0.020468 -0.943868 27.86718 1